Presentation, Treatment, and Clinical Outcomes of Patients With Hepatocellular Carcinoma, With and Without Human Immunodeficiency Virus Infection

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 11, 2012, Pages 1284-1290

  Yopp, Adam C ^a   Subramanian, Madhu ^a   Jain, Mamta K ^b   Mansour, John C ^a   Schwarz, Roderich E ^a   Balch, Glen C ^a   Singal, Amit G ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Coinfection; HBV; HCV; Liver cancer; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CHEMOEMBOLIZATION; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER SURGERY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84867728892     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.08.010     Document Type: Article

References (20)

1. Parkin D.M., Bray F., Ferlay J., et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156.
2. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999, 340:745-750.
3. Weber R., Sabin C.A., Friis-Møller N., et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006, 166:1632-1641.
4. Rosenthal E., Pialoux G., Bernard N., et al. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 study). J Viral Hepat 2007, 14:183-188.
5. Sulkowski M.S., Thomas D.L. Hepatitis C in the HIV-infected patient. Clin Liver Dis 2003, 7:179-194.
6. Patel P., Hanson D.L., Sullivan P.S., et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008, 148:728-736.
7. Brau N., Fox R.K., Xiao P., et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol 2007, 47:527-537.
8. García-Samaniego J., Rodríguez M., Berenguer J., et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001, 96:179-183.
9. Puoti M., Bruno R., Soriano V., et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 2004, 18:2285-2293.
10. Berretta M., Garlassi E., Cacopardo B., et al. Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist 2011, 16:1258-1269.
11. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2005, 42:1208-1236. Practice Guidelines Committee, American Association for the Study of Liver Diseases.
12. Okuda K., Ohtsuki T., Obata H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985, 56:918-925.
13. Clifford G.M., Rickenbach M., Polesel J., et al. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS 2008, 22:2135-2141.
14. Giordano T.P., Kramer J.R., Souchek J., et al. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med 2004, 164:2349-2354.
15. Bruno R., Sacchi P., Filice C., et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis: an emerging issue. J Acquir Immune Defic Syndr 2002, 30:535-536.
16. Bourcier V., Winnock M., Ait Ahmed M., et al. Primary liver cancer is more aggressive in HIV-HCC coinfection than in HCV infection: prospective study (ANRS CO13 Hepavih and CO12 Cirvir). Clin Res Hepatol Gastroenterol 2012, 36:214-221.
17. Estimated lifetime risk for diagnosis of HIV infection among Hispanics/Latinos: 37 states and Puerto Rico. MMWR Morb Mortal Wkly Rep 2010, 59:1297-1301. CDC.
18. Singal A.G., Yopp A., Skinner C.S., et al. Utilization of hepatocellular carcinoma surveillance among American patients: a systemic review. J Gen Intern Med 2012, 27:861-867.
19. Davila J.A., Henderson L., Kramer J.R., et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med 2011, 154:85-93.
20. Singal A.G., Volk M.L., Rakoski M.O., et al. Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma. J Clin Gastroenterol 2011, 45:727-732.